Sofie Wengander1, Penelope Trimpou1,2, Eleni Papakokkinou1,2, Oskar Ragnarsson1,2. 1. Department of Internal Medicine and Clinical Nutrition, Institute of Medicine at Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden. 2. Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden.
Abstract
INTRODUCTION: Epidemiological studies on the incidence of Cushing's syndrome (CS) are few and most often includes only patients with the most common form, that is Cushing's disease (CD). OBJECTIVE: To analyse the incidence of endogenous CS in an unselected cohort of patients from western Sweden between 2002 and 2017. METHODS: Medical records from patients who had received a diagnostic code for CS and adrenocortical carcinoma in the Västra Götaland County between 2002 and 2017 were reviewed. Eighty-two patients had been diagnosed with endogenous CS in the region during the study period and were included in this analysis. RESULTS: Thirty-nine patients (48%) had CD, 21 (26%) had ectopic ACTH-producing tumour, 17 (21%) had a benign adrenal CS, and 5 (6%) had cortisol-producing adrenocortical carcinoma. Nine of 21 (43%) patients with ectopic CS had an ACTH-producing lung tumour, 4 had a neuroendocrine pancreas tumour, and 5 had an occult tumour. The annual incidence of endogenous CS was 3.2 cases per million/y; 1.5 for CD, 0.8 for ectopic CS, 0.7 for benign adrenal CS and 0.2 for adrenocortical carcinoma. CONCLUSIONS: Approximately three new cases of endogenous CS, per one million inhabitants, were diagnosed annually between 2002 and 2017. Compared with previous reports, proportionally more patients had ectopic CS. The reason for this is unclear although increased awareness of hypercortisolism in patients with malignant tumours in the modern era is a possible explanation.
INTRODUCTION: Epidemiological studies on the incidence of Cushing's syndrome (CS) are few and most often includes only patients with the most common form, that is Cushing's disease (CD). OBJECTIVE: To analyse the incidence of endogenous CS in an unselected cohort of patients from western Sweden between 2002 and 2017. METHODS: Medical records from patients who had received a diagnostic code for CS and adrenocortical carcinoma in the Västra Götaland County between 2002 and 2017 were reviewed. Eighty-two patients had been diagnosed with endogenous CS in the region during the study period and were included in this analysis. RESULTS: Thirty-nine patients (48%) had CD, 21 (26%) had ectopic ACTH-producing tumour, 17 (21%) had a benign adrenal CS, and 5 (6%) had cortisol-producing adrenocortical carcinoma. Nine of 21 (43%) patients with ectopic CS had an ACTH-producing lung tumour, 4 had a neuroendocrine pancreas tumour, and 5 had an occult tumour. The annual incidence of endogenous CS was 3.2 cases per million/y; 1.5 for CD, 0.8 for ectopic CS, 0.7 for benign adrenal CS and 0.2 for adrenocortical carcinoma. CONCLUSIONS: Approximately three new cases of endogenous CS, per one million inhabitants, were diagnosed annually between 2002 and 2017. Compared with previous reports, proportionally more patients had ectopic CS. The reason for this is unclear although increased awareness of hypercortisolism in patients with malignant tumours in the modern era is a possible explanation.
Authors: Eva L Alba; Emily A Japp; Gustavo Fernandez-Ranvier; Ketan Badani; Eric Wilck; Munir Ghesani; Andrea Wolf; Edward M Wolin; Virginia Corbett; David Steinmetz; Maria Skamagas; Alice C Levine Journal: J Endocr Soc Date: 2022-05-06
Authors: Roberta Armignacco; Anne Jouinot; Lucas Bouys; Amandine Septier; Thomas Lartigue; Mario Neou; Cassandra Gaspar; Karine Perlemoine; Leah Braun; Anna Riester; Fidéline Bonnet-Serrano; Anne Blanchard; Laurence Amar; Carla Scaroni; Filippo Ceccato; Gian Paolo Rossi; Tracy Ann Williams; Casper K Larsen; Stéphanie Allassonnière; Maria-Christina Zennaro; Felix Beuschlein; Martin Reincke; Jérôme Bertherat; Guillaume Assié Journal: Eur J Endocrinol Date: 2022-01-13 Impact factor: 6.664
Authors: Padiporn Limumpornpetch; Ann W Morgan; Ana Tiganescu; Paul D Baxter; Victoria Nyawira Nyaga; Mar Pujades-Rodriguez; Paul M Stewart Journal: J Clin Endocrinol Metab Date: 2022-07-14 Impact factor: 6.134
Authors: Regin Jay Mallari; Jai Deep Thakur; Garni Barkhoudarian; Amy Eisenberg; Amanda Rodriguez; Sarah Rettinger; Pejman Cohan; Lynnette Nieman; Daniel F Kelly Journal: J Clin Endocrinol Metab Date: 2022-01-01 Impact factor: 5.958